Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update G Shiha, A Ibrahim, A Helmy, SK Sarin, M Omata, A Kumar, D Bernstien, ... Hepatology international 11, 1-30, 2017 | 254 | 2017 |
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) G Shiha, SK Sarin, AE Ibrahim, M Omata, A Kumar, LA Lesmana, N Leung, ... Hepatology international 3 (2), 323-333, 2009 | 136 | 2009 |
Risk factors for developing hepatocellular carcinoma in Egypt A Omar, GK Abou-Alfa, A Khairy, H Omar Chinese clinical oncology 2 (4), 43-43, 2013 | 89 | 2013 |
Respiratory viral infection in lung transplantation induces exosomes that trigger chronic rejection M Gunasekaran, S Bansal, R Ravichandran, M Sharma, S Perincheri, ... The Journal of Heart and Lung Transplantation 39 (4), 379-388, 2020 | 84 | 2020 |
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ... Gut 71 (3), 593-604, 2022 | 81 | 2022 |
Extracorporeal membrane oxygenation as a bridge to lung transplantation: a single-center experience in the present era EM Todd, SB Roy, AS Hashimi, R Serrone, R Panchanathan, P Kang, ... The Journal of thoracic and cardiovascular surgery 154 (5), 1798-1809, 2017 | 60 | 2017 |
TRUGENE sequencing versus INNO‐LiPA for sub‐genotyping of HCV genotype‐4 ARN Zekri, HM Alam El‐Din, AA Bahnassy, AMR El‐Shehabi, ... Journal of medical virology 75 (3), 412-420, 2005 | 51 | 2005 |
Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers A Mostafa, S Kandil, MH El-Sayed, S Girgis, H Hafez, M Yosef, S Saber, ... International journal of epidemiology 50 (1), 50-61, 2021 | 45 | 2021 |
Health-related quality of life in Egyptian patients after liver transplantation M Mabrouk, G Esmat, A Yosry, M El-Serafy, W Doss, N Zayed, ... Annals of Hepatology 11 (6), 882-890, 2012 | 33 | 2012 |
Genetic distance and heterogenecity between quasispecies is a critical predictor to IFN response in Egyptian patients with HCV genotype-4 ARN Zekri, HMA El-Din, AA Bahnassy, MM Khaled, A Omar, I Fouad, ... Virology journal 4, 1-12, 2007 | 31 | 2007 |
Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: a retrospective analysis M Sharma, M Gunasekaran, R Ravichandran, CE Fisher, AP Limaye, ... The Journal of Heart and Lung Transplantation 39 (11), 1210-1219, 2020 | 28 | 2020 |
The role of donor-derived exosomes in lung allograft rejection R Ravichandran, S Bansal, M Rahman, M Sharma, W Liu, A Bharat, ... Human immunology 80 (8), 588-594, 2019 | 28 | 2019 |
Interictal electrocardiographic and echocardiographic changes in patients with generalized tonic-clonic seizures MM Ramadan, N El-Shahat, AA Omar, M Gomaa, T Belal, SA Sakr, ... International heart journal 54 (3), 171-175, 2013 | 27 | 2013 |
Recurrence of hepatitis C virus (genotype 4) infection after living-donor liver transplant in Egyptian patients A Yosry, M Abdel-Rahman, G Esmat, M El-Serafy, A Omar, W Doss, ... Exp Clin Transplant 7 (3), 157-63, 2009 | 26 | 2009 |
The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease Y Fouad, G Esmat, R Elwakil, S Zakaria, A Yosry, I Waked, M El-Razky, ... Saudi Journal of Gastroenterology 28 (1), 3-20, 2022 | 24 | 2022 |
Donor outcomes in right lobe adult living donor liver transplantation: single-center experience in Egypt G Esmat, A Yosry, M El-Serafi, A Omar, W Doss, A Hosny, A Ghali, ... Transplantation proceedings 37 (7), 3147-3150, 2005 | 24 | 2005 |
The “Golden Hours” algorithm for the management of the multisystem inflammatory syndrome in children (MIS-C) S Mahmoud, EM Fouda, A Kotby, HM Ibrahim, M Gamal, YG El Gendy, ... Global Pediatric Health 8, 2333794X21990339, 2021 | 22 | 2021 |
The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patients D Attia, K El Saeed, W Elakel, T El Baz, A Omar, A Yosry, MH Elsayed, ... Alimentary pharmacology & therapeutics 47 (9), 1296-1305, 2018 | 22 | 2018 |
Plasma levels of resistin and ghrelin before and after treatment in patients with hyperthyroidism SS Abd El Gawad, F El-Kenawy, AA Mousa, AA Omar Endocrine practice 18 (3), 376-381, 2012 | 21 | 2012 |
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a phase II trial (ESLC01 study) HA Azim, A Omar, H Atef, H Zawahry, MK Shaker, AHK Abdelmaksoud, ... Journal of hepatocellular carcinoma, 109-119, 2018 | 19 | 2018 |